Genetic News and Research

RSS

Touchlight announces leadership transition, with Will Downie appointed interim CEO

Touchlight today announces that Karen Fallen is stepping down as CEO and that the Board of Directors has appointed Will Downie as Interim Chief Executive Officer.

From Touchlight 21 Oct 2026

Duke initiative aims to bring dementia AI tools into clinical practice

Artificial intelligence (AI) could transform care for older adults and people living with dementia, but few tools have successfully moved from research into routine clinical practice.

21 Oct 2026

CT scans reveal body composition changes preceding pancreatic cancer diagnosis

People who develop pancreatic cancer experience measurable changes in body composition years before diagnosis that differ from those seen in similar individuals without cancer, according to a Mayo Clinic study led by former Mayo Clinic research fellow, Aleksander Bogdanski and published in Pancreatology.

20 Oct 2026

UC Davis Health introduces five-day accelerated treatment for severe depression

UC Davis Health has added an accelerated treatment approach for depression at its Advanced Psychiatric Therapeutics (APT) clinic in East Sacramento.

20 Oct 2026

Researchers identify new depression subtype linked to the body clock

Research by experts at the University of Sydney has identified a new subtype of depression called "circadian depression".

20 Oct 2026

Why the same healthy diet may not work the same way for everyone

A review published in Nutrients proposes a seven-pillar precision nutrition framework that combines biological, behavioral, and environmental information to tailor dietary interventions throughout life. The authors identify potential benefits for cardiovascular, respiratory, blood, and sleep health, while emphasizing the need for further clinical trials to establish effective, accessible, and personalized nutritional strategies.

20 Oct 2026

Experts weigh risks of using gene therapies for common diseases

Gene therapy is no longer the future of medicine - it's reality. Treatments that replace, silence or edit genes are already changing clinical care.

20 Oct 2026

Liquid biopsy reliably detects early-stage lung cancer recurrence risk

Despite advances in early-stage lung cancer treatment, a significant number of patients experience disease recurrence after surgery or initial therapy.

20 Oct 2026

Novel "Raman genome" concept enables rapid tracking of viruses

A research team led by Distinguished Professor Giuseppe Pezzotti at the Biomedical Engineering Center, Kansai Medical University, has demonstrated that differences in the molecular structures of viral RNA can be captured as "Raman barcodes," enabling the identification of 20 SARS-CoV-2 variants and subvariants.

20 Oct 2026

Discovery of new bacteria opens fresh avenues for prostate cancer research

University of East Anglia researchers have discovered the genetic blueprints of 18 new bacterial species collected from prostate cancer patients.

20 Oct 2026

New gene-editing platform gives doctors control over cell therapies

An Australian clinician-led research team has developed a gene-editing platform that could give doctors more control over cell therapies, making them more practical for patients with complex immune conditions.

20 Oct 2026

A study of 62.5 million people reveals what broad ethnic labels miss about rare diseases

Researchers analyzing health records from 62.5 million people in England found that the prevalence of 406 rare diseases varied substantially between ethnic communities, with important differences concealed by broad ethnic classifications. Recorded COVID-19 infections were also more common among people with the studied rare diseases (32.8% versus 29.0%), although differences in age, disease composition, and testing practices may have influenced these findings.

19 Oct 2026

Researchers use mitochondrial uncouplers to target breast cancer metastasis

Mitochondrial serine catabolic pathway (MSCP), also called serine, glycine, and one-carbon metabolism, is essential for cancer cells to produce amino acids, one-carbon units, and reducing equivalents.

19 Oct 2026

Study links DNA methylation to OCD psychotherapy treatment response

OCD is a mental health disorder characterized by unwanted, recurring thoughts and repetitive behaviors that can severely interfere with everyday life. Exposure-based psychotherapy is one of the most effective treatments, but the biological mechanisms underlying treatment response remain poorly understood.

19 Oct 2026

Antibody patterns may predict inflammatory bowel disease years before diagnosis

A large-scale study, presented today at UEG Week 2026, has identified distinct antibody patterns up to 10 years before the diagnosis of inflammatory bowel disease (IBD), potentially opening new avenues for earlier risk detection and providing insights into future disease course.

19 Oct 2026

Antibiotic exposure during childhood linked to higher risk of IBS in young adults

Antibiotic use from childhood through early adulthood was associated with higher odds of irritable bowel syndrome (IBS) at age 24, with the odds increasing as the number of antibiotic prescriptions rose, according to a new study presented today at UEG Week 2026.

19 Oct 2026

Your age may not tell the whole story about your health, but your blood could

Researchers analyzed plasma metabolites from 18,476 individuals aged 1 to 96 years and developed two metabolomic aging measures to assess biological aging, chronic disease, and mortality risk. Accelerated metabolomic aging was associated with greater risks of chronic disease and death, while a separate mortality-linked measure provided additional information about health status and disease burden beyond conventional clinical assessments.

18 Oct 2026

Study identifies priority genes for safer prescribing in older Chinese patients

A research team has identified three genes that could help prioritize pharmacogenomic testing for older adults in China who receive multiple medications.

15 Oct 2026

Nearly one in three women with autoimmune diseases waited at least four years for a diagnosis, survey finds

An international study of 6,607 adults with autoimmune diseases found that female participants reported longer diagnostic delays, more clinician visits, and higher rates of perceived psychiatric and psychosomatic misdiagnoses than males. The findings suggest sex-related differences in diagnostic experiences, although the researchers cautioned that patient-reported misdiagnoses were not independently verified and the causes of these disparities remain uncertain.

15 Oct 2026

A protective brain enzyme may counteract aging-associated cognitive decline

Cinzia Vicidomini, PhD, and Amar Sahay, PhD, of the Mass General Brigham Department of Psychiatry, the Harvard Stem Cell Institute and the Broad Institute of Harvard and MIT, are the lead and senior authors of a paper published in Nature Neuroscience, "An aging-sensitive secreted phospholipase confers neuroprotection and cognitive resilience."

15 Oct 2026